Florida Senate - 2009 SENATOR AMENDMENT Bill No. CS for CS for CS for SB 1986 Barcode 953014 LEGISLATIVE ACTION Senate . House . . . Floor: 8/AD/2R . 04/23/2009 05:39 PM . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— Senator Bennett moved the following: 1 Senate Amendment (with directory and title amendments) 2 3 Between lines 3473 and 3474 4 insert: 5 (4) ANNUAL REPORTS.— 6 (a) Where coverage for routine patient care costs 7 associated with care provided in a phase 1, phase 2, phase 3, or 8 phase 4 cancer clinical trial is denied, a carrier shall, after 9 consulting academic and community oncologists involved in cancer 10 care and clinical research, submit to the Office of Insurance 11 Regulation in a format prescribed by rule, an annual report that 12 shall include: 13 1. The number of denials for coverage of routine patient 14 care cost as defined in paragraph (c) in cancer clinical trials; 15 and 16 2. A comparison of the costs of routine patient care 17 provided in the trials in question compared to the costs of 18 standard therapies for the same diagnosis. 19 (b) The Office of Insurance Regulation shall provide annual 20 reports required under paragraph (a) to the Governor, President 21 of the Senate, the Speaker of the House of Representatives, and 22 the Secretary for Health Care Administration no later than 30 23 days before the regular legislative session. 24 (c) For purposes of this section, the term “routine patient 25 care cost” means physician fees, laboratory expenses, and 26 expenses associated with the hospitalization, administration of 27 treatment, and evaluation of a patient during the course of 28 treatment which are consistent with usual and customary patterns 29 and standards of care incurred whenever an enrollee, subscriber, 30 or insured receives medical care associated with an approved 31 cancer clinical trial, and which would be covered if such items 32 and services were provided other than in connection with an 33 approved cancer clinical trial but does not include the direct 34 cost of the clinical trial. 35 36 ====== D I R E C T O R Y C L A U S E A M E N D M E N T ====== 37 And the directory clause is amended as follows: 38 Delete lines 3462 - 3463 39 and insert: 40 Section 66. Paragraph (b) of subsection (1) of section 41 627.4239, Florida Statutes, is amended, present subsection (4) 42 is renumbered as subsection (5), and a new subsection (4) is 43 added to that section to read: 44 45 ================= T I T L E A M E N D M E N T ================ 46 And the title is amended as follows: 47 Delete lines 284 - 286 48 and insert: 49 F.S.; conforming provisions; amending s. 627.4239, 50 F.S.; revising the term “standard reference 51 compendium” for purposes of regulating the insurance 52 coverage of drugs used in the treatment of cancer; 53 requiring a carrier to submit an annual report 54 regarding the coverage of routine patient care costs 55 to the Office of Insurance Regulation under certain 56 circumstances; requiring the Office of Insurance 57 Regulation to provide the annual report to the 58 Governor, Legislature, and the Secretary of Health 59 Care Administration; providing a definition; amending 60 s. 651.118, F.S.; conforming a